We are live on ! Find out more
RCEL icon

Avita Medical

84 hedge funds and large institutions have $98.2M invested in Avita Medical in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more call options, than puts

Call options by funds: $538K | Put options by funds: $244K

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

5% more funds holding

Funds holding: 8084 (+4)

3.84% less ownership

Funds ownership: 31.86%28.01% (-3.8%)

17% less capital invested

Capital invested by funds: $119M → $98.2M (-$20.6M)

37% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 27

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
17
Reduced
27
Closed
18
Calls
$538K
Puts
$244K
Net Calls
+$294K
Net Calls Change
+$266K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
101
Federated Hermes
Pennsylvania
-$10.2K -697 Closed
SHIM
102
Stone House Investment Management
Pennsylvania
-$1.04K -71 Closed

RCEL Hedge Fund Activity: Q4 2023 in Review

84 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2023, worth a combined $98.2M — down 17% from $119M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RCEL positions and 18 closed out — a net gain of 4 holders — while 17 added to existing stakes and 27 trimmed.

The largest buyer was AWM Investment Company, opening a new position worth an estimated $5.7M. The largest seller was Russell Investments Group, cutting an estimated $4.22M.

  • 84 institutional investors held Avita Medical (RCEL) as of Q4 2023, up from 80 in Q3 2023.
  • Funds reported $98.2M of Avita Medical stock for Q4 2023, down 17% quarter-over-quarter.
  • 22 funds opened new Avita Medical positions in Q4 2023 and 18 closed out, a net change of +4 holders.
  • The largest Avita Medical buyer in Q4 2023 was AWM Investment Company, an estimated $5.7M added.
  • The largest Avita Medical seller in Q4 2023 was Russell Investments Group, an estimated $4.22M sold.

Based on aggregated 13F filings for Q4 2023.